Original document(16 pages)  中文版
    A Chinese medicine in the form of pill, dripping pill, tablet or soft capsule for treating the diseases in urinary system is prepared from 8 Chinese-medicinal materials including lysimachia, tuckahoe, plantain bark, imperate rhizome, etc through extracting in water, concentating, adding additives and shaping. Its quality control method is also disclosed.
Application Number
申请号
200510032580 Application Date
申请日
2005.12.20
Title 名称 Chinese medicinal preparation for treating urinary system disease, its preparation method and quality control method
Publication Number
公开号
1824178 Publication Date
公开日
2006.08.30
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A61K36/899,A61K9/16,A61K9/20,A61K9/48,A61P13/00
Applicant(s) Name
申请人
Wang Hengxin
Address 地址 410007
Inventor(s) Name 发明人
Attorney & Agent 代理人

  
Mutually intersecting network polymer multi-colour water-coluble figure paint
Chinese medicine formulation for nourishing yin to lessen fire, and its preparing method
Traditional Chinese medicinal prepn. for tonifying kidney Yang and promoting the circulation of qi and water, and its prepn. method
Novel oral liquor for invigorating spleen, and prepn. method and quality control therefor
Oral preparation of 'Guipixin', method for preparing same and quality control
Injection of Herba Andrographitis, and its prepn. method
Traditional Chinese medicinal prepn. for treating respiratory tract infection, and its prepn. method
Traditional Chinese medicinal prepn. for treating intestinal tract diseases, and its prepn. method
Traditional Chinese medicinal prepn. for relieving exterior syndrome, dispelkling cold, ventilating lung and relieving cough, and prepn. method
Traditional Chinese medicine preparation for reinforcing body fluid and nourishing the blood, its preparation method and quality control method
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.